Induction of programmed death of tumor cells by activation of betal integrin.
Induction of programmed death of tumor cells by activation of betal integrin.
批准号:
17590074
负责人:
FUKAI Fumio
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
研究TNIII通过刺激β1整合素活化诱导肿瘤细胞程序性死亡的分子机制。tniii诱导的β 1整合素激活诱导FAK (Tyr397)、FAK (Tyr 925)、Src (Tyr397)和Akt的去磷酸化,导致WI38VA13纤维肉瘤样细胞发生caspase非依赖性凋亡死亡。这种细胞凋亡伴随着AIF的核易位,已知与caspase非依赖性细胞凋亡有关。此外,TNIII刺激Rac活化和随后产生活性氧香料(ROS),提示ROS参与了TNIII诱导的凋亡细胞死亡。有趣的是,tniii诱导的正常成纤维细胞的反应与肿瘤细胞的反应明显不同。TNIII完全拯救了正常成纤维细胞NIH3T3免于血清剥夺的凋亡,其中Ras处于静息状态被激活。与之形成鲜明对比的是,TNIII诱导了纤维肉瘤样WI38VA13细胞的凋亡死亡,其中处于组成性活性状态的Ras短暂失活。为了解释细胞对TNIII反应的差异,构建了稳定表达Ras组成型活性突变体(NIH-V7)的NIH3T3细胞。当NIH-V7细胞与TNIII孵育时,细胞发生程序性死亡,并伴有Ras的短暂失活。因此,TNIII似乎具有通过刺激Ras激活来控制细胞存活/凋亡的能力,其中Ras的激活状态可能是细胞存活或凋亡的重要决定因素。
英文摘要
Molecular mechanism by which TNIII induces programmed death of tumor cells through stimulating β1 integrin activation was investigated. TNIII-induced activation of βl integrins induced dephosphorylation of FAK (Tyr397), FAK (Tyr 925), Src (Tyr 397) and Akt, resulting in caspase-independent apoptotic death of WI38VA13 fibrosarcoma-like cells. This apoptosis was accompanied by the nuclear translocation of AIF that is known to be implicated in caspase-independent apoptosis. Additionally, TNIII stimulated Rac activation and subsequent generation of reactive oxygen spices (ROS), suggesting the involvement of ROS in the TNIII-induced apoptotic cell death.Interestingly, TNIII-induced response of normal fibroblasts was clearly distinct from that of tumor cells. TNIII completely rescued mormal fibroblasts NIH3T3 from the serum-deprived apoptosis, in which Ras in a resting state was activated. In sharp contrast, TNIII elicited apoptotic death against fibrosarcoma-like WI38VA13 cells, in which Ras in a constitutively active state was transiently inactivated. To explain this difference in cellular response to TNIII, NIH3T3 cells stably expressing constitutively active mutant of Ras (NIH-V7) were constructed. When NIH-V7 cells were incubated with TNIII, the cells underwent programmed death in concomitant with a transient inactivation of Ras.Thus, TNIII appears to have the ability to control cell survival/apoptosis by stimulating Ras activation, in which the activation status of Ras may be an important determinant whether cells survive or undergo apoptosis.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
抗がん剤
抗癌剂
DOI:
--
发表时间:
2019
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.2183/pjab.82.181
发表时间:
2006-05-01
期刊:
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
影响因子:
3.1
作者:
[Asakawa, Hideo, Sasabe, Masataka, Takasaki, Seiichi]
通讯作者:
Takasaki, Seiichi
Molecular mechanism for malignant cell transformationinduced by a peptide derived from tenascin C through integrin activation
-
批准号:23590090
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.58万
-
财政年份:2011
-
负责人:FUKAI Fumio
-
依托单位:
Identification of a membrane receptor mediating the biological effects of the fibronectin-derivedantiadhesive peptide FNIII 14.
-
批准号:11680615
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.64万
-
财政年份:1999
-
负责人:FUKAI Fumio
-
依托单位:
Adipocyte differentiation of ST-13 cells induced by fibronectin fragment
-
批准号:06680698
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:FUKAI Fumio
-
依托单位:
Molecular mechanism of fibronectin-induced chemotactic migration
-
批准号:04680173
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1992
-
负责人:FUKAI Fumio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
-
批准号:82300764
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:郑茜子
-
依托单位:
Tenascin-C促进巨噬细胞向肌成纤维细胞转化在肾脏纤维化中的作用机制研究
-
批准号:82300792
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:田媛
-
依托单位:
Tenascin R在阿尔茨海默病发生发展中的作用和机制研究
-
批准号:82371435
-
项目类别:面上项目
-
资助金额:47万元
-
批准年份:2023
-
负责人:王叶冉
-
依托单位:
RET-M918T突变通过调控Tenascin C-EGFR复合体形成促进甲状腺髓样癌干性和侵袭转移的机制研究
-
批准号:82373008
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:史潇
-
依托单位:
基于类器官探究Tenascin-C小分子多肽对肾纤维化的防治作用及其机制
-
批准号:82300761
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:梁剑青
-
依托单位:
柔肝方下调Tenascin-C改善HIF-1α/PFKFB3介导的巨噬细胞糖酵解抗肝纤维化的机制研究
-
批准号:82374249
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:李曼
-
依托单位:
肺泡上皮细胞过度内质网应激释放外泌体Tenascin-C放大炎症效应加重脓毒症急性肺损伤
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:刘友坦
-
依托单位:
壁层上皮细胞来源的Tenascin C在新月体肾炎中的作用研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张敏
-
依托单位:
细胞外基质蛋白Tenascin-X多途径调控肝细胞癌进展转移的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:吴琼
-
依托单位:
Tenascin-C 下调ABCA1 表达促动脉粥样硬化及机制研究
-
批准号:2022JJ30535
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:汤石林
-
依托单位: